Carini; David J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Carini; David J..The latest application filed is for "piperidine amide derivatives as hiv attachment inhibitors".

Company Profile

0.28.15

Carini; David J. - Clarendon VT
Carini; David J. - Wallingford CT
Carini; David J. - Wilmington DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Piperidine amide derivatives as HIV attachment inhibitors Grant 9,505,752 - Wang , et al. November 29, 2	2016-11-29
Piperidine Amide Derivatives As Hiv Attachment Inhibitors App 20150210684 - Wang; Tao ; et al.	2015-07-30
Diketopiperidine derivatives as HIV attachment inhibitors Grant 8,242,124 - Regueiro-Ren , et al. August 14, 2	2012-08-14
Diketo substituted pyrrolo[2,3-C]pyridines Grant 8,124,615 - Wang , et al. February 28, 2	2012-02-28
Diketo Fused Azolopiperidines And Azolopiperazines As Anti-hiv Agents App 20110212971 - Wang; Tao ; et al.	2011-09-01
Diketo substituted pyrrolo[2,3-c] pyridines Grant 7,960,406 - Wang , et al. June 14, 2	2011-06-14
Diketo-piperazine and piperidine derivatives as antiviral agents Grant 7,807,671 - Wang , et al. October 5, 2	2010-10-05
Diketo-Piperazine and Piperidine derivatives as antiviral agents Grant 7,807,676 - Wang , et al. October 5, 2	2010-10-05
Hepatitis C virus inhibitors Grant 7,772,183 - Carini , et al. August 10, 2	2010-08-10
HMG-CoA reductase inhibitors Grant 7,659,281 - Stein , et al. February 9, 2	2010-02-09
Diketo Fused Azolopiperidines and Azolopiperazines as Anti-HIV Agents App 20100009993 - Wang; Tao ; et al.	2010-01-14
Diketopiperidine Derivatives as HIV Attachment Inhibitors App 20090325985 - Regueiro-Ren; Alicia ; et al.	2009-12-31
Diketo-piperazine And Piperidine Derivatives As Antiviral Agents App 20080139572 - Wang; Tao ; et al.	2008-06-12
Diketo-piperazine And Piperidine Derivatives As Antiviral Agents App 20070249579 - Wang; Tao ; et al.	2007-10-25
HMG-CoA reductase inhibitors App 20070249583 - Stein; Philip D. ; et al.	2007-10-25
Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents Grant 7,250,435 - Nugiel , et al. July 31, 2	2007-07-31
Hepatitis C virus inhibitors App 20070093414 - Carini; David J. ; et al.	2007-04-26
Macrocyclic isoquinoline peptide inhibitors of hepatitis C virus Grant 7,173,004 - McPhee , et al. February 6, 2	2007-02-06
Alpha, alpha-disubstituted benzylglycine derivatives as HIV protease inhibitors App 20060128634 - Carini; David J.	2006-06-15
Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents App 20050261353 - Nugiel, David A. ; et al.	2005-11-24
N-cycloalkylglycines as HIV protease inhibitors Grant 6,943,170 - Carini September 13, 2	2005-09-13
Macrocyclic isoquinoline peptide inhibitors of Hepatitis C virus App 20050090432 - McPhee, Fiona ; et al.	2005-04-28
Semicarbazides and their uses Grant 6,849,631 - Carini February 1, 2	2005-02-01
Semicarbazides and their uses App 20040242869 - Carini, David J.	2004-12-02
N-cycloalkylglycines as HIV protease inhibitors App 20040142878 - Carini, David J.	2004-07-22
Semicarbazides and their uses App 20020091127 - Carini, David J.	2002-07-11
Indeno [1,2-c] pyrazol-4-ones and their uses Grant 6,407,103 - Nugiel , et al. June 18, 2	2002-06-18
Indeno [1,2-c]pyrazol-4-ones and their uses App 20010027195 - Nugiel, David A. ; et al.	2001-10-04
Acylsemicarbazides and their uses Grant 6,291,504 - Nugiel , et al. September 18, 2	2001-09-18
Angiotensin II receptor blocking imidazoles Grant 5,354,867 - Carini , et al. October 11, 1	1994-10-11
Substituted pyrazole angiotensin II antagonists Grant 5,315,013 - Carini , et al. May 24, 1	1994-05-24
Fused aryl substituted imidazole angiotensin II receptor inhibitors Grant 5,254,546 - Ardecky , et al. October 19, 1	1993-10-19
Treatment of chronic renal failure with imidazole angiotensin-II receptor antagonists Grant 5,210,079 - Carini , et al. May 11, 1	1993-05-11
Substituted 1,2,3 triazole angiotensin II antagonists Grant 5,189,048 - Carini , et al. February 23, 1	1993-02-23
Method and composition for preventing NSAID-induced renal failure Grant 5,155,118 - Carini , et al. October 13, 1	1992-10-13
Treatment of hypertension with angiotensin II blocking imidazoles Grant 5,153,197 - Carini , et al. October 6, 1	1992-10-06
Angiotensin II receptor blocking imidazoles Grant 5,138,069 - Carini , et al. August 11, 1	1992-08-11
Treatment of congestive heart failure with angiotensin 11 receptor blocking imidazoles Grant 5,128,355 - Carini , et al. July 7, 1	1992-07-07
Substituted 1,2,4-triazole angiotensin II antagonists Grant 5,093,346 - Carini , et al. March 3, 1	1992-03-03
Substituted 1,2,3-triazole angiotensin II antagonists Grant 5,081,127 - Carini , et al. January 14, 1	1992-01-14
Combination .beta.-blocking/angiotensin II blocking antihypertensives Grant 4,916,129 - Carini , et al. April 10, 1	1990-04-10
Angiotensin II receptor blocking benzimidazoles Grant 4,880,804 - Carini , et al. November 14, 1	1989-11-14
Antihypertensive alkyl-arylimidazole, thiazole and oxazole derivatives Grant 4,632,930 - Carini , et al. December 30, 1	1986-12-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.